CRL Stock Recent News

CRL LATEST HEADLINES

CRL Stock News Image - zacks.com

Investors remain optimistic about Charles River (CRL), owing to its acquisitions, thriving DSA segment and financial stability.

zacks.com 2024 May 30
CRL Stock News Image - businesswire.com

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks. Based on decades of viral vector contract development and manufacturing organization (CDMO) experience, the Company has designed a methodical program to drive successful, accelerated process transfer to its Maryland-based viral vector center of excellence (CoE) in as little as nine months.

businesswire.com 2024 May 30
CRL Stock News Image - zacks.com

Charles River's (CRL) RMS arm sees lesser impact on demand than other life science sectors despite macroeconomic challenges in China.

zacks.com 2024 May 24
CRL Stock News Image - Zacks Investment Research

Explore Charles River's (CRL) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks Investment Research 2024 May 13
CRL Stock News Image - Zacks Investment Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research 2024 May 13
CRL Stock News Image - Zacks Investment Research

Charles River's (CRL) Manufacturing and RMS business segments report organic revenue growth.

Zacks Investment Research 2024 May 09
CRL Stock News Image - Zacks Investment Research

The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research 2024 May 09
CRL Stock News Image - Zacks Investment Research

Get a deeper insight into the potential performance of Charles River (CRL) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Investment Research 2024 May 06
CRL Stock News Image - Zacks Investment Research

Investors interested in stocks from the Medical Services sector have probably already heard of Icon PLC (ICLR) and Charles River Laboratories (CRL). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research 2024 Apr 29
CRL Stock News Image - Zacks Investment Research

Growth across Microbial Solutions and Biologics Testing businesses is likely to have contributed to Charles River's (CRL) Q1 revenues, offset by lower sales volume in the small model business.

Zacks Investment Research 2024 Apr 24
10 of 50